Genetic Effects of Chemotherapy on Sperm

PRINCIPAL INVESTIGATOR:

  • Kyle Orwig, PhD

INCLUSION CRITERIA for enrollment into the study are:

  • Adult males ages 18 through 50
  • Scheduled to undergo treatment with chemotherapy for a medical indication
  • Participants must not have any prior chemotherapy or radiation treatments
  • Participants with oligospermia (very low sperm counts) or azospermia (absent sperm count) will be excluded

DESCRIPTION:

The Fertility Preservation Program in Pittsburgh is conducting an experimental research study for adult male patients facing chemotherapy treatment. For these patients, semen will be collected prior to chemotherapy and after initiating chemotherapy. The majority of the sample collected before chemotherapy will be reserved for your clinical use in the future.

COMPENSATION:

Your insurance provider will be charged for the costs of semen analysis and collection of the sample taken before chemotherapy as this is standard of care. The FPP Program will cover the cost of semen cryopreservation and storage for the first year. You will not be charged any fees associated with semen samples collected after chemotherapy as these are research only samples.

FOR MORE INFORMATION PLEASE CONTACT US:

412-641-7475
FertilityPreservation@upmc.edu